InfuSystem Holdings, Inc. (INFU) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $9.99. It has a SharesGrow Score of 78/100, indicating a strong investment profile with 5 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of INFU = $18.65 (+86.7% from the current price, the stock appears undervalued). Analyst consensus target is INFU = $15 (+50.2% upside).
Valuation: INFU trades at a trailing Price-to-Earnings (P/E) of 28.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.17.
Financials: revenue is $143M, +9.3%/yr average growth. Net income is $7M, growing at +1698.7%/yr. Net profit margin is 4.6% (thin). Gross margin is 56% (-0.9 pp trend).
Balance sheet: total debt is $3M against $57M equity (Debt-to-Equity (D/E) ratio 0.06, conservative). Current ratio is 1.8 (strong liquidity). Debt-to-assets is 3.4%. Total assets: $101M.
Analyst outlook: 3 / 3 analysts rate INFU as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 78/100 (Pass), Growth 83/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 54/100 (Partial), Future 100/100 (Pass), Income 30/100 (Fail).
